Cosette wants out but Mayne finds a pulse
WeBull is preparing to wage 'price war' in fight for financial advisers.
Nervous dealmakers await Chalmers' final Mayne-Cosette deal decision.
BBRC billionaire Brett Blundy demands Victoria’s Secret board change.
MaxCap Group is bullish despite growing pile of bad debt.
Cboe’s Australian ambitions vanish before the opening bell
Canva could risk product bloat to defend its moat before an IPO.
Activists team up to fight 'extremely problematic' Humm takeover.
Kirkland & Ellis lawyers trained on communication style after investor hostilities.
Norway's $2t sovereign fund joins James Hardie shareholder revolt.
CSL faces shareholder reckoning at AGM after $40b rout.
The Mayne Pharma v Cosette battle was a formative experience for G+T partners.
